The Reproductive Safety of Psychotropic Medication and Implications for Prescribing in the Perinatal Period

View at publisher Summarise with VIRAT
Authors: Angelika Wieck
Cited by: 0
References: 62

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Making decisions about prescribing medication for mental disorders in childbearing women is a task that may have profound and long-lasting implications for a mother and her family, and it is important that prescribers have access to up-to-date summaries and interpretations of research that examines how safe these medications are in pregnancy and lactation. Because it is not possible to test a drug’s reproductive safety in randomised controlled trials, research has to rely on less rigorous study designs. The inherent difficulties and other methodological problems have meant that interpretation of the evidence has often been difficult. However, the volume and quality of research has dramatically increased in recent years. Current findings concerning antidepressant, antipsychotic and mood-stabilising medication during pregnancy and lactation are summarised in this chapter, and recommendations for clinical practice are made referring to published guidelines where they are available.

Fields of Study & Subjects

Pregnancy and Medication Impact Maternal Mental Health During Pregnancy and Postpartum Pharmacological Effects and Toxicity Studies

Publication details

Journal / source
Cambridge University Press eBooks
Pages
468–489
Publication date
27 March 2026
Language
EN
Document type
Book chapter